Regulatory3 Aug 2026, 06:32 pm
Artemis Medicare Services: Monitoring Agency Report for Q2 2026
AI Summary
Artemis Medicare Services Ltd has submitted its Monitoring Agency Report for the quarter ended June 30, 2026, prepared by CARE Ratings Limited. The report, in relation to a Preferential Issue of ₹330 crore, confirms no deviation from the objects of the issue. The report has been reviewed by the company's Audit Committee and is available on the company's investor website. CARE Ratings Limited acts as the Monitoring Agency as per SEBI regulations and the Monitoring Agency Agreement dated April 03, 2024.
Key Highlights
- Monitoring Agency Report for Q2 2026 submitted by Artemis Medicare Services.
- Report pertains to utilization of proceeds from a ₹330 crore Preferential Issue.
- CARE Ratings Limited is the appointed Monitoring Agency.
- No deviation from the objects of the preferential issue was reported.
- Report reviewed by the Audit Committee and available on the company website.
Price Impact
More from ARTEMISMED